Cargando…

Beyond lipid lowering: pleiotropic effects of statins in heart failure

Detalles Bibliográficos
Autor principal:	Swenne, C. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2013
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751029/ https://www.ncbi.nlm.nih.gov/pubmed/23904190 http://dx.doi.org/10.1007/s12471-013-0460-5

Ejemplares similares

Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
por: Kamberi, Lulzim Selim, et al.
Publicado: (2012)

Pleiotropic use of Statins as non-lipid-lowering drugs
por: Zhang, Qijia, et al.
Publicado: (2020)

Role of Lactone and Acid Forms in the Pleiotropic Effects of Statins
por: Preta, Giulio
Publicado: (2022)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Psychosocial distress under pressure
por: Swenne, C. A.
Publicado: (2014)

Diverging opinions about shared decisions
por: Swenne, C. A.
Publicado: (2014)

Atherosclerosis at your fingertips?
por: Swenne, C.A.
Publicado: (2015)

Therapeutic implications of statins beyond lipid lowering: In the perspective of their effects on the antigen presentation, T cells and NKT cells
por: Khan, Masood Alam
Publicado: (2021)

Pleiotropic effects of statins
por: Kavalipati, Narasaraju, et al.
Publicado: (2015)

Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect
por: Raggi, Paolo, et al.
Publicado: (2019)

PCSK9 and Calcific Aortic Valve Stenosis: Moving Beyond Lipids
por: Leopold, Jane A.
Publicado: (2020)

Are pleiotropic effects of statins real?
por: Corsini, Alberto, et al.
Publicado: (2007)

Statins in Variant Angina
por: Kim, Jang-Young
Publicado: (2013)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
por: Morofuji, Yoichi, et al.
Publicado: (2022)

Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
por: Mann, Douglas L., et al.
Publicado: (2017)

The reduction of post-cardiac surgery infections by statins: solid evidence?
por: Bekkers, S. C. A. M.
Publicado: (2014)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Oxytocin: A New Therapeutic for Heart Failure?
por: Habecker, Beth A.
Publicado: (2020)

Pleiotropic Effects of Statins in the Perioperative Setting
por: Galyfos, George, et al.
Publicado: (2017)

Hydrogen Sulfide Therapy Promotes Beneficial Systemic Effects in Experimental Heart Failure
por: Nabeebaccus, Adam A., et al.
Publicado: (2018)

The Role of Macrophages in Nonischemic Heart Failure
por: Chen, Bijun, et al.
Publicado: (2018)

A Growth Tonic for Heart Failure?
por: Bishopric, Nanette H.
Publicado: (2016)

Radiomics for prediction of survival in lower-grade gliomas—it’s time to move beyond the crystal ball
por: Pinto dos Santos, Daniel, et al.
Publicado: (2020)

Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
por: Mączewski, Michał
Publicado: (2018)

SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs
por: Ciulla, Michele M.
Publicado: (2020)

Appropriate candidates for statin use in heart failure
por: Seo, Hong Seog
Publicado: (2014)

Lifelong statins for long life in dialysis patients?
por: Ebert, Thomas, et al.
Publicado: (2023)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Brain-derived neurotrophic factor in heart failure
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Ongoing Clinical Trials of the Pleiotropic Effects of Statins
por: Davignon, Jean, et al.
Publicado: (2005)

Understanding the molecular mechanisms of statin pleiotropic effects
por: German, Charles A., et al.
Publicado: (2023)

Promoting Health Equity in Heart Failure Amid a Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2021)

Metabolic Coupling as a Therapeutic Strategy for Heart Failure
por: Young, Martin E.
Publicado: (2019)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Pleiotropic vasoprotective effects of statins: The chicken or the egg?
por: Kirmizis, Dimitrios, et al.
Publicado: (2009)

Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins
por: Cai, Anping, et al.
Publicado: (2015)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart Failure
por: Wollert, Kai C.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q91hpvo347h525c1ksu658f2ho